nodes	percent_of_prediction	percent_of_DWPC	metapath
Terbinafine—CYP2C8—Spironolactone—dilated cardiomyopathy	0.0751	1	CbGbCtD
Terbinafine—Acute generalised exanthematous pustulosis—Furosemide—dilated cardiomyopathy	0.0414	0.0451	CcSEcCtD
Terbinafine—Depressive symptom—Lisinopril—dilated cardiomyopathy	0.0298	0.0325	CcSEcCtD
Terbinafine—Gastrointestinal symptom NOS—Spironolactone—dilated cardiomyopathy	0.0271	0.0296	CcSEcCtD
Terbinafine—Drug eruption—Spironolactone—dilated cardiomyopathy	0.0259	0.0283	CcSEcCtD
Terbinafine—Bullous eruption—Furosemide—dilated cardiomyopathy	0.0219	0.0239	CcSEcCtD
Terbinafine—Rash erythematous—Spironolactone—dilated cardiomyopathy	0.0208	0.0227	CcSEcCtD
Terbinafine—Vasculitis—Spironolactone—dilated cardiomyopathy	0.0163	0.0178	CcSEcCtD
Terbinafine—Eruption—Furosemide—dilated cardiomyopathy	0.0141	0.0154	CcSEcCtD
Terbinafine—Drug eruption—Furosemide—dilated cardiomyopathy	0.0141	0.0154	CcSEcCtD
Terbinafine—Appetite absent—Lisinopril—dilated cardiomyopathy	0.0131	0.0143	CcSEcCtD
Terbinafine—Ear disorder—Lisinopril—dilated cardiomyopathy	0.0121	0.0131	CcSEcCtD
Terbinafine—Cholestasis—Furosemide—dilated cardiomyopathy	0.0114	0.0125	CcSEcCtD
Terbinafine—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.0104	0.0114	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.0104	0.0114	CcSEcCtD
Terbinafine—Psoriasis—Lisinopril—dilated cardiomyopathy	0.0104	0.0113	CcSEcCtD
Terbinafine—Gastritis—Spironolactone—dilated cardiomyopathy	0.0102	0.0112	CcSEcCtD
Terbinafine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00991	0.0108	CcSEcCtD
Terbinafine—Jaundice cholestatic—Furosemide—dilated cardiomyopathy	0.00987	0.0108	CcSEcCtD
Terbinafine—Hearing impaired—Furosemide—dilated cardiomyopathy	0.00911	0.00993	CcSEcCtD
Terbinafine—Vasculitis—Furosemide—dilated cardiomyopathy	0.00889	0.00969	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00884	0.00964	CcSEcCtD
Terbinafine—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00832	0.00907	CcSEcCtD
Terbinafine—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00803	0.00876	CcSEcCtD
Terbinafine—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00776	0.00846	CcSEcCtD
Terbinafine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00757	0.00825	CcSEcCtD
Terbinafine—Jaundice cholestatic—Lisinopril—dilated cardiomyopathy	0.00741	0.00807	CcSEcCtD
Terbinafine—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00717	0.00782	CcSEcCtD
Terbinafine—Alopecia—Spironolactone—dilated cardiomyopathy	0.00708	0.00771	CcSEcCtD
Terbinafine—Deafness—Furosemide—dilated cardiomyopathy	0.00704	0.00767	CcSEcCtD
Terbinafine—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0067	0.00731	CcSEcCtD
Terbinafine—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00667	0.00727	CcSEcCtD
Terbinafine—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00667	0.00727	CcSEcCtD
Terbinafine—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00659	0.00718	CcSEcCtD
Terbinafine—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00651	0.00709	CcSEcCtD
Terbinafine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00647	0.00705	CcSEcCtD
Terbinafine—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00632	0.00689	CcSEcCtD
Terbinafine—Malaise—Spironolactone—dilated cardiomyopathy	0.00629	0.00685	CcSEcCtD
Terbinafine—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00615	0.0067	CcSEcCtD
Terbinafine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00586	0.00639	CcSEcCtD
Terbinafine—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00582	0.00635	CcSEcCtD
Terbinafine—Confusional state—Spironolactone—dilated cardiomyopathy	0.00574	0.00625	CcSEcCtD
Terbinafine—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00569	0.0062	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00567	0.00618	CcSEcCtD
Terbinafine—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00567	0.00618	CcSEcCtD
Terbinafine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00557	0.00607	CcSEcCtD
Terbinafine—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00541	0.00589	CcSEcCtD
Terbinafine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00539	0.00587	CcSEcCtD
Terbinafine—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00538	0.00587	CcSEcCtD
Terbinafine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00534	0.00582	CcSEcCtD
Terbinafine—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00526	0.00573	CcSEcCtD
Terbinafine—Eczema—Lisinopril—dilated cardiomyopathy	0.00526	0.00573	CcSEcCtD
Terbinafine—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00519	0.00565	CcSEcCtD
Terbinafine—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00497	0.00542	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00491	0.00535	CcSEcCtD
Terbinafine—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00488	0.00532	CcSEcCtD
Terbinafine—Arthritis—Lisinopril—dilated cardiomyopathy	0.00486	0.0053	CcSEcCtD
Terbinafine—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00484	0.00528	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00481	0.00524	CcSEcCtD
Terbinafine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00469	0.00511	CcSEcCtD
Terbinafine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00459	0.005	CcSEcCtD
Terbinafine—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00453	0.00494	CcSEcCtD
Terbinafine—Urticaria—Spironolactone—dilated cardiomyopathy	0.00452	0.00493	CcSEcCtD
Terbinafine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0045	0.0049	CcSEcCtD
Terbinafine—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00425	0.00464	CcSEcCtD
Terbinafine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00425	0.00464	CcSEcCtD
Terbinafine—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00423	0.00461	CcSEcCtD
Terbinafine—Visual impairment—Furosemide—dilated cardiomyopathy	0.0042	0.00458	CcSEcCtD
Terbinafine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00419	0.00457	CcSEcCtD
Terbinafine—Gastritis—Lisinopril—dilated cardiomyopathy	0.00418	0.00456	CcSEcCtD
Terbinafine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00412	0.00449	CcSEcCtD
Terbinafine—Influenza—Lisinopril—dilated cardiomyopathy	0.00408	0.00445	CcSEcCtD
Terbinafine—Eye disorder—Furosemide—dilated cardiomyopathy	0.00407	0.00444	CcSEcCtD
Terbinafine—Tinnitus—Furosemide—dilated cardiomyopathy	0.00406	0.00443	CcSEcCtD
Terbinafine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00404	0.00441	CcSEcCtD
Terbinafine—Propranolol—ADRB1—dilated cardiomyopathy	0.00404	0.543	CrCbGaD
Terbinafine—Pruritus—Spironolactone—dilated cardiomyopathy	0.00402	0.00439	CcSEcCtD
Terbinafine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.004	0.00436	CcSEcCtD
Terbinafine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00395	0.00431	CcSEcCtD
Terbinafine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00394	0.00429	CcSEcCtD
Terbinafine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00389	0.00424	CcSEcCtD
Terbinafine—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00388	0.00423	CcSEcCtD
Terbinafine—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00382	0.00416	CcSEcCtD
Terbinafine—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.0038	0.00414	CcSEcCtD
Terbinafine—Erythema—Furosemide—dilated cardiomyopathy	0.00379	0.00413	CcSEcCtD
Terbinafine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00376	0.0041	CcSEcCtD
Terbinafine—Flatulence—Furosemide—dilated cardiomyopathy	0.00374	0.00407	CcSEcCtD
Terbinafine—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00373	0.00406	CcSEcCtD
Terbinafine—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00371	0.00405	CcSEcCtD
Terbinafine—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00369	0.00403	CcSEcCtD
Terbinafine—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00365	0.00397	CcSEcCtD
Terbinafine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00362	0.00394	CcSEcCtD
Terbinafine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00361	0.00393	CcSEcCtD
Terbinafine—Rash—Spironolactone—dilated cardiomyopathy	0.00359	0.00391	CcSEcCtD
Terbinafine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00358	0.00391	CcSEcCtD
Terbinafine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00357	0.0039	CcSEcCtD
Terbinafine—Headache—Spironolactone—dilated cardiomyopathy	0.00356	0.00388	CcSEcCtD
Terbinafine—Jaundice—Lisinopril—dilated cardiomyopathy	0.00355	0.00387	CcSEcCtD
Terbinafine—Anaemia—Furosemide—dilated cardiomyopathy	0.00351	0.00382	CcSEcCtD
Terbinafine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00344	0.00375	CcSEcCtD
Terbinafine—Vertigo—Furosemide—dilated cardiomyopathy	0.00341	0.00371	CcSEcCtD
Terbinafine—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.0034	0.0037	CcSEcCtD
Terbinafine—Propranolol—ADRB2—dilated cardiomyopathy	0.0034	0.457	CrCbGaD
Terbinafine—Nausea—Spironolactone—dilated cardiomyopathy	0.00338	0.00368	CcSEcCtD
Terbinafine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00327	0.00356	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00321	0.0035	CcSEcCtD
Terbinafine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00316	0.00344	CcSEcCtD
Terbinafine—Confusional state—Furosemide—dilated cardiomyopathy	0.00312	0.0034	CcSEcCtD
Terbinafine—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.0031	0.00337	CcSEcCtD
Terbinafine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00309	0.00337	CcSEcCtD
Terbinafine—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00305	0.00332	CcSEcCtD
Terbinafine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00304	0.00331	CcSEcCtD
Terbinafine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00303	0.0033	CcSEcCtD
Terbinafine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00301	0.00328	CcSEcCtD
Terbinafine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00297	0.00323	CcSEcCtD
Terbinafine—Anorexia—Furosemide—dilated cardiomyopathy	0.00295	0.00322	CcSEcCtD
Terbinafine—Alopecia—Lisinopril—dilated cardiomyopathy	0.00289	0.00315	CcSEcCtD
Terbinafine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00286	0.00312	CcSEcCtD
Terbinafine—Erythema—Lisinopril—dilated cardiomyopathy	0.00285	0.0031	CcSEcCtD
Terbinafine—Flatulence—Lisinopril—dilated cardiomyopathy	0.0028	0.00306	CcSEcCtD
Terbinafine—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00279	0.00304	CcSEcCtD
Terbinafine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00278	0.00303	CcSEcCtD
Terbinafine—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00274	0.00298	CcSEcCtD
Terbinafine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00269	0.00293	CcSEcCtD
Terbinafine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00268	0.00292	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00267	0.00291	CcSEcCtD
Terbinafine—Fatigue—Furosemide—dilated cardiomyopathy	0.00267	0.00291	CcSEcCtD
Terbinafine—Pain—Furosemide—dilated cardiomyopathy	0.00265	0.00289	CcSEcCtD
Terbinafine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00264	0.00288	CcSEcCtD
Terbinafine—Anaemia—Lisinopril—dilated cardiomyopathy	0.00263	0.00287	CcSEcCtD
Terbinafine—Angioedema—Lisinopril—dilated cardiomyopathy	0.0026	0.00283	CcSEcCtD
Terbinafine—Malaise—Lisinopril—dilated cardiomyopathy	0.00257	0.0028	CcSEcCtD
Terbinafine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00256	0.00279	CcSEcCtD
Terbinafine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00255	0.00278	CcSEcCtD
Terbinafine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00253	0.00276	CcSEcCtD
Terbinafine—Cough—Lisinopril—dilated cardiomyopathy	0.00248	0.00271	CcSEcCtD
Terbinafine—Urticaria—Furosemide—dilated cardiomyopathy	0.00246	0.00268	CcSEcCtD
Terbinafine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00245	0.00267	CcSEcCtD
Terbinafine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00245	0.00267	CcSEcCtD
Terbinafine—Myalgia—Lisinopril—dilated cardiomyopathy	0.00242	0.00264	CcSEcCtD
Terbinafine—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00242	0.00264	CcSEcCtD
Terbinafine—Chest pain—Lisinopril—dilated cardiomyopathy	0.00242	0.00264	CcSEcCtD
Terbinafine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00241	0.00263	CcSEcCtD
Terbinafine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00241	0.00262	CcSEcCtD
Terbinafine—Discomfort—Lisinopril—dilated cardiomyopathy	0.00239	0.00261	CcSEcCtD
Terbinafine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00237	0.00258	CcSEcCtD
Terbinafine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00234	0.00255	CcSEcCtD
Terbinafine—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00232	0.00253	CcSEcCtD
Terbinafine—Infection—Lisinopril—dilated cardiomyopathy	0.00231	0.00251	CcSEcCtD
Terbinafine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00228	0.00249	CcSEcCtD
Terbinafine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00227	0.00248	CcSEcCtD
Terbinafine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00226	0.00246	CcSEcCtD
Terbinafine—Asthenia—Furosemide—dilated cardiomyopathy	0.00222	0.00242	CcSEcCtD
Terbinafine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00221	0.00241	CcSEcCtD
Terbinafine—Pruritus—Furosemide—dilated cardiomyopathy	0.00219	0.00239	CcSEcCtD
Terbinafine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00212	0.00231	CcSEcCtD
Terbinafine—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00212	0.00231	CcSEcCtD
Terbinafine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00209	0.00227	CcSEcCtD
Terbinafine—Dizziness—Furosemide—dilated cardiomyopathy	0.00205	0.00223	CcSEcCtD
Terbinafine—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00204	0.00223	CcSEcCtD
Terbinafine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00202	0.0022	CcSEcCtD
Terbinafine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.002	0.00219	CcSEcCtD
Terbinafine—Fatigue—Lisinopril—dilated cardiomyopathy	0.002	0.00218	CcSEcCtD
Terbinafine—Pain—Lisinopril—dilated cardiomyopathy	0.00199	0.00216	CcSEcCtD
Terbinafine—Vomiting—Furosemide—dilated cardiomyopathy	0.00197	0.00215	CcSEcCtD
Terbinafine—Rash—Furosemide—dilated cardiomyopathy	0.00195	0.00213	CcSEcCtD
Terbinafine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00195	0.00213	CcSEcCtD
Terbinafine—Headache—Furosemide—dilated cardiomyopathy	0.00194	0.00211	CcSEcCtD
Terbinafine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00191	0.00209	CcSEcCtD
Terbinafine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.0019	0.00207	CcSEcCtD
Terbinafine—Urticaria—Lisinopril—dilated cardiomyopathy	0.00184	0.00201	CcSEcCtD
Terbinafine—Nausea—Furosemide—dilated cardiomyopathy	0.00184	0.002	CcSEcCtD
Terbinafine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00184	0.002	CcSEcCtD
Terbinafine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00184	0.002	CcSEcCtD
Terbinafine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00171	0.00187	CcSEcCtD
Terbinafine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00167	0.00182	CcSEcCtD
Terbinafine—Pruritus—Lisinopril—dilated cardiomyopathy	0.00164	0.00179	CcSEcCtD
Terbinafine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00159	0.00173	CcSEcCtD
Terbinafine—Dizziness—Lisinopril—dilated cardiomyopathy	0.00154	0.00167	CcSEcCtD
Terbinafine—Vomiting—Lisinopril—dilated cardiomyopathy	0.00148	0.00161	CcSEcCtD
Terbinafine—Rash—Lisinopril—dilated cardiomyopathy	0.00146	0.0016	CcSEcCtD
Terbinafine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00146	0.00159	CcSEcCtD
Terbinafine—Headache—Lisinopril—dilated cardiomyopathy	0.00145	0.00159	CcSEcCtD
Terbinafine—Nausea—Lisinopril—dilated cardiomyopathy	0.00138	0.0015	CcSEcCtD
